Nucleic acid ligands to the prostate specific membrane antigen
US6933114B2 · kind B2 · utility
5Cited by
8References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2001 |
| Grant date | Aug 23, 2005 |
| Priority date | — |
| Expiry date | Mar 15, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/322
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Methods are provided for generating nucleic acid ligands of Prostate Specific Membrane Antigen (PSMA). The methods of the invention use the SELEX method for the isolation of nucleic acid ligands. The invention also includes nucleic acid ligands to PSMA, and methods and compositions for the treatment and diagnosis of disease using the nucleic acid ligands.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.